Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical outcome measures in rheumatoid arthritis.

Authors: M L Prevoo; P L van Riel; M A van 't Hof; M H van Rijswijk; M A van Leeuwen; H H Kuper; L B van de Putte
Journal: Br J Rheumatol Date: 1993-07

6. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria.

Authors: A M van Gestel; M L Prevoo; M A van 't Hof; M H van Rijswijk; L B van de Putte; P L van Riel
Journal: Arthritis Rheum Date: 1996-01

7. Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity.

Authors: J S Smolen; F C Breedveld; G Eberl; I Jones; M Leeming; G L Wylie; J Kirkpatrick
Journal: Arthritis Rheum Date: 1995-01

8. Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent?

Authors: D T Felson; J J Anderson; M L Lange; G Wells; M P LaValley
Journal: Arthritis Rheum Date: 1998-09

9. Preliminary criteria for clinical remission in rheumatoid arthritis.

Authors: R S Pinals; A T Masi; R A Larsen
Journal: Arthritis Rheum Date: 1981-10

10. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.

Authors: D T Felson; J J Anderson; M Boers; C Bombardier; M Chernoff; B Fried; D Furst; C Goldsmith; S Kieszak; R Lightfoot
Journal: Arthritis Rheum Date: 1993-06

33 in total

1. Impact of tight control strategy on rheumatoid arthritis in Sarawak.

Authors: Cheng Lay Teh; Jin Shyan Wong
Journal: Clin Rheumatol Date: 2010-10-01 Impact factor: 2.980

2. Consensus statement on the use of rituximab in patients with rheumatoid arthritis.

Authors: J S Smolen; E C Keystone; P Emery; F C Breedveld; N Betteridge; G R Burmester; M Dougados; G Ferraccioli; U Jaeger; L Klareskog; T K Kvien; E Martin-Mola; K Pavelka
Journal: Ann Rheum Dis Date: 2006-10-26 Impact factor: 19.103

3. Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results.

Authors: D van der Heijde; L Klareskog; M Boers; R Landewé; C Codreanu; H D Bolosiu; R Pedersen; S Fatenejad
Journal: Ann Rheum Dis Date: 2005-04-28 Impact factor: 19.103

4. Effects of long-term corticosteroid usage on functional disability in patients with early rheumatoid arthritis, regardless of controlled disease activity.

Authors: Eiichi Tanaka; Ajitha Mannalithara; Eisuke Inoue; Noriko Iikuni; Atsuo Taniguchi; Shigeki Momohara; Gurkirpal Singh; Hisashi Yamanaka
Journal: Rheumatol Int Date: 2010-12-16 Impact factor: 2.631

5. Measuring inflammation in rheumatoid arthritis with a new clinical and ultrasound index: development and initial validation.

Authors: Juan José de Agustín; Alba Erra; Andrés Ponce; Carmen Moragues; Cesar Díaz-Torné; Delia Reina; Estefanía Moreno; Julio Ramírez; Lourdes Mateo; Manel Pujol Busquets; Patricia Moya; Pilar Santo-Panero; Sergi Ros-Expósito; Javier Narváez; Raimon Sanmartí; Mª Jesús García de Yébenes; Loreto Carmona
Journal: Rheumatol Int Date: 2019-08-08 Impact factor: 2.631

6. Adalimumab and methotrexate is more effective than adalimumab alone in patients with established rheumatoid arthritis: results from a 6-month longitudinal, observational, multicentre study.

Authors: M S Heiberg; E Rødevand; K Mikkelsen; C Kaufmann; A Didriksen; P Mowinckel; T K Kvien
Journal: Ann Rheum Dis Date: 2006-05-05 Impact factor: 19.103

7. Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis.

Authors: J J Haringman; M C Kraan; T J M Smeets; K H Zwinderman; P P Tak
Journal: Ann Rheum Dis Date: 2003-08 Impact factor: 19.103

8. Infliximab treatment for rheumatoid arthritis, with dose titration based on the Disease Activity Score: dose adjustments are common but not always sufficient to assure sustained benefit.

Authors: P Sidiropoulos; G Bertsias; H D Kritikos; H Kouroumali; K Voudouris; D T Boumpas
Journal: Ann Rheum Dis Date: 2004-02 Impact factor: 19.103

9. Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism.

Authors: Petra Bohanec Grabar; Dusan Logar; Boris Lestan; Vita Dolzan
Journal: Eur J Clin Pharmacol Date: 2008-07-08 Impact factor: 2.953

10. The pattern and clinical manifestations of rheumatoid arthritis in Sarawak General Hospital.

Authors: C L Teh; J S Wong
Journal: Clin Rheumatol Date: 2008-09-05 Impact factor: 2.980